NCT06704191View on ClinicalTrials.gov

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 21, 2025

Primary Completion Date

June 6, 2026

Study Completion Date

June 6, 2026

Conditions
Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8
Interventions
BIOLOGICAL

BCG Solution

Given intravesically

PROCEDURE

Cystoscopy

Undergo cystoscopy

DRUG

Docetaxel

Given intravesically

DRUG

Gemcitabine

Given intravesically

OTHER

Home Health Encounter

Receive access to CCBW home health visits

DRUG

Mitomycin

Given intravesically

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Mayo Clinic

OTHER

NCT06704191 - In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial | Biotech Hunter | Biotech Hunter